Structure Therapeutics In... (GPCR)
27.00
1.62 (6.38%)
At close: Jan 15, 2025, 10:58 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Revenue | n/a | n/a | n/a | n/a |
| Cost of Revenue | 949.17K | 623.26K | 266.35K | 20.03K |
| Gross Profit | -949.17K | -623.26K | -266.35K | -20.03K |
| Operating Income | -102.78M | -52.56M | -37.70K | -15.91K |
| Interest Income | 13.38M | 1.26M | 122.00 | 168.29K |
| Pretax Income | -89.38M | -51.30M | -37.82K | -15.74K |
| Net Income | -89.62M | -51.32M | -38.05K | -15.88K |
| Selling & General & Admin | 32.67M | 16.37M | 8.59K | 3.54K |
| Research & Development | 70.10M | 36.19M | 29.11K | 12.36K |
| Other Expenses | 0.00 | n/a | n/a | n/a |
| Operating Expenses | 102.78M | 52.56M | 37.70K | 15.91K |
| Interest Expense | 13.39M | n/a | 122.16K | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
| Cost & Expenses | 102.78M | 52.56M | 37.70K | 15.91K |
| Income Tax | 236.00K | 17.00K | 231.00 | 138.00 |
| Shares Outstanding (Basic) | 36.73M | 36.59M | 36.59M | 36.59M |
| Shares Outstanding (Diluted) | 36.73M | 36.59M | 36.59M | 36.59M |
| EPS (Basic) | -2.44 | -1.4 | -0.00 | -0.00 |
| EPS (Diluted) | -2.44 | -1.4 | -0.00 | -0.00 |
| EBITDA | -102.46M | -52.28M | -37.62M | -15.75M |
| Depreciation & Amortization | 316.00K | 623.26K | 266.35K | 20.03K |